Clinical Trials Logo

Clinical Trial Summary

A comparative effectiveness research design was used. The sample size was calculated to 136 patients, who were randomized to an intervention group and a control group respectively. The patients were terminal ill patients enrolled to three in-bed hospices in Denmark and nausea and vomiting were measured using EORTC QlQ-c15-PAL (European Organisation for Research and Treatment of Cancer, Quality of Life Questionaire, core 15, Palliation)


Clinical Trial Description

The terminal ill patient is suffering from many different symptoms. In total 70% are suffering from nausea and vomiting due to the wide spread of cancer or due to side effects of treatment. Often the antiemetic's are not able to reduce symptoms to a level that enable the patient to experience quality in life in the last days of his life. The investigators had some experience with acupuncture as a complementary therapy but the investigators wanted more systematically to investigate if acupuncture is able to reduce the terminal ill patient´s nausea and vomiting. Literature show that acupuncture is able to reduce nausea and vomiting in patients receiving chemotherapy, but there is no literature that support the ability of acupuncture to reduce nausea and vomiting in the terminal ill patient.

The purpose of this study was to generate evidence based knowledge close to practice regarding the effect of acupuncture in reducing nausea and vomiting in the terminal ill patient.

Participants:

Terminal ill patients suffering from nausea and/or vomiting

Interventions:

The intervention group received usual care plus acupuncture for three days. The acupuncture spots: Pericardium-6, Stomach-36, Liver-3 and Yin Tang were used. The control group received usual care. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04378998
Study type Interventional
Source University of Aarhus
Contact
Status Completed
Phase N/A
Start date January 25, 2015
Completion date October 25, 2019

See also
  Status Clinical Trial Phase
Completed NCT04078815 - End-of-life Practices in 2019 vs. 2014
Recruiting NCT04750395 - Comparing Haloperidol and Olanzapine in Treating Terminal Delirium Phase 2
Recruiting NCT06108375 - Differences in Acceptability of Music Therapy Sessions Played Live Compared to a Recording Thereof N/A
Completed NCT04030910 - 'LIFEView' Audiovisual Technology: Virtual Travel to Support Wellbeing and Quality of Life at the End of Life N/A
Completed NCT04568629 - ADJUST: A Study on MDT Prognostication N/A
Completed NCT03520270 - Prevalence of Potentially Inappropriate Treatments
Enrolling by invitation NCT05625854 - Using a Fan With Aromatherapy in Breathlessness Patients in Terminal Illness N/A
Recruiting NCT04257227 - Transcranial Magnetic Stimulation for Psychological Distress in Patients With Advanced Illness N/A
Completed NCT04678310 - iLIVE Volunteer Study
Completed NCT04456647 - Parenteral Nutrition Therapy in Patients With Incurable Cancer
Completed NCT02362295 - Prospective National Survey of the Palliative Situation Among Inmates in French Prisons N/A
Terminated NCT03886753 - Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products
Active, not recruiting NCT04950608 - Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care Phase 2
Completed NCT03336489 - Evaluation of the Organization of Continuity of Care for Home Hospice Patients by Four Parisian Health Networks
Completed NCT03392857 - End Of Life in the Critically Ill patiEnt
Completed NCT03697213 - The Surprise Study
Completed NCT01367613 - Open-Label Treatment Extension of Protocol MNTX 302 Phase 3
Recruiting NCT04612738 - Project Talk Trial: Engaging Underserved Communities in End-of-life Conversations N/A
Completed NCT02067572 - A Randomized Controlled Trial Evaluating the Effectiveness of a Salvia-based Mouthwash in Palliative Care N/A
Withdrawn NCT03041571 - Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students